Detection of Recurrent Cervical Cancer and Prediction of Its Patient Survival with Serum Squamous-Cell Carcinoma-Antigen and 2-[18F] Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography.
Nan-Jing PengChin HuYu-Li ChiuChang-Ching YuGiou-Teng YiangJim Jinn-Chyuan SheuAn-Jen ChiangPublished in: Diagnostics (Basel, Switzerland) (2020)
Serum SCC-Ag could predict tumor recurrence and the survival of patients with SqCC cervical cancer. As such, the surgical resection of limited recurrent disease, as determined using FDG-PET/CT, might improve the survival of patients with cervical cancer. MTV and TLG may serve as a prognostic biomarker of survival in patients with recurrent cervical cancer.
Keyphrases
- positron emission tomography
- computed tomography
- free survival
- squamous cell carcinoma
- magnetic resonance imaging
- type diabetes
- pet ct
- pet imaging
- insulin resistance
- adipose tissue
- magnetic resonance
- rectal cancer
- skeletal muscle
- case report
- blood glucose
- image quality
- metabolic syndrome
- contrast enhanced
- locally advanced